Global Onychomycosis Market Size study & Forecast, by Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Other Types) by Treatment (Oral, Topical, Others) and Regional Analysis, 2022-2029

Description

List of Tables

Global Onychomycosis Market is valued at approximately USD 3.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.56% over the forecast period 2022-2029. Onychomycosis is a fungal infection of the nails, and can also be referred to as dermatophytic onychomycosis. This can be a cause of dermatophytes and nondermatophytic molds. The symptoms begin with physical alterations to the nail and surrounding skin. The nail and tissue frequently turn white or yellow, and the nails might thicken and become brittle, making them more likely to break. Physical problems in this condition might deteriorate noticeably and cause pain and inflammation if not managed. The high prevalence of Onychomycosis infections, increasing investments in the R&D of novel drugs, increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs are the factors driving the growth of the market.

According to the National Library of Medicine, there is 10% of the Onychomycosis infected population across the globe. Trichophyton rubrum was estimated to be the main infecting organism. Nondermatophyte mould and dermatophytes are the other causes of Onychomycosis infections. T. rubrum organisms were found in 98% of the infections. Additionally, The R&D expenditure in the pharmaceutical industry amounted to 83 billion dollars in 2019. Between 2010 and 2019, the Food and Drug Administration (FDA) approved 38 new medications on average, which is 60% more than it did on an annual average over the preceding ten years. Increasing Onychomycosis infections and increasing R&D investments and development of new drugs are the major factors driving the market growth. Other important components driving market increase are the increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs. Furthermore, rising awareness about the treatment of Onychomycosis and the growing Diabetic Population are the factors creating major market opportunities in the forecast period. However, the lack of awareness of onychomycosis infections stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Onychomycosis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of Onychomycosis infections, increasing healthcare expenditures, increase in the awareness of Onychomycosis drugs, and increasing government initiatives in R&D. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as high incidence of Onychomycosis infections, a growing geriatric population, increasing urbanization and focus of key players on investing in R&D.

Major market players included in this report are:

Bausch Health Companies Inc.
Gsk Plc
Abbott
Pfizer Inc.
Bayer Ag
Teva Pharmaceutical Industries, Ltd.
Cipla Inc.
Novartis Ag
Sun Pharmaceutical Industries Ltd.
Merck & Co., Inc.

Recent Developments in the Market:

In March 2021, The Tianjin Institute of Pharmaceutical Research and HUYABIO International joint venture, submitted a new drug application efinaconazole, as Jublia™ for the treatment of onychomycosis.
In July 2021, Kaken Pharmaceutical (KKPCF) and Almirall S.A., a global biopharmaceutical company specializing in skin health, announced that they have signed a license and distribution agreement under which Kaken Pharmaceutical gives Almirall the exclusive right to develop and market the topical formulation of efinaconazole in Europe.

Global Onychomycosis Market Report Scope:

Historical Data 2019-2020-2021

Base Year for Estimation 2021

Forecast period 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Type, Treatment, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Other Types

By Treatment:

Oral
Topical
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Onychomycosis Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Onychomycosis Market, by Type, 2019-2029 (USD Billion)
- 1.2.3. Onychomycosis Market, by Treatment, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Onychomycosis Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Onychomycosis Market Dynamics

3.1. Onychomycosis Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. High prevalence of Onychomycosis infections
  - 3.1.1.2. Increasing investments in the R&D of novel drugs
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of awareness of onychomycosis infections
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising awareness about the treatment of Onychomycosis
  - 3.1.3.2. Growing Diabetic Population

Chapter 4. Global Onychomycosis Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Onychomycosis Market, by Type

6.1. Market Snapshot
6.2. Global Onychomycosis Market by Type, Performance - Potential Analysis
6.3. Global Onychomycosis Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Onychomycosis Market, Sub Segment Analysis
- 6.4.1. Distal Subungual Onychomycosis
- 6.4.2. White Superficial Onychomycosis
- 6.4.3. Proximal Subungual Onychomycosis
- 6.4.4. Other Types

Chapter 7. Global Onychomycosis Market, by Treatment

7.1. Market Snapshot
7.2. Global Onychomycosis Market by Treatment, Performance - Potential Analysis
7.3. Global Onychomycosis Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
7.4. Onychomycosis Market, Sub Segment Analysis
- 7.4.1. Oral
- 7.4.2. Topical
- 7.4.3. Others

Chapter 8. Global Onychomycosis Market, Regional Analysis

8.1. Onychomycosis Market, Regional Market Snapshot
8.2. North America Onychomycosis Market
- 8.2.1. U.S. Onychomycosis Market
  - 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Treatment breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Onychomycosis Market
8.3. Europe Onychomycosis Market Snapshot
- 8.3.1. U.K. Onychomycosis Market
- 8.3.2. Germany Onychomycosis Market
- 8.3.3. France Onychomycosis Market
- 8.3.4. Spain Onychomycosis Market
- 8.3.5. Italy Onychomycosis Market
- 8.3.6. Rest of Europe Onychomycosis Market
8.4. Asia-Pacific Onychomycosis Market Snapshot
- 8.4.1. China Onychomycosis Market
- 8.4.2. India Onychomycosis Market
- 8.4.3. Japan Onychomycosis Market
- 8.4.4. Australia Onychomycosis Market
- 8.4.5. South Korea Onychomycosis Market
- 8.4.6. Rest of Asia Pacific Onychomycosis Market
8.5. Latin America Onychomycosis Market Snapshot
- 8.5.1. Brazil Onychomycosis Market
- 8.5.2. Mexico Onychomycosis Market
8.6. Rest of The World Onychomycosis Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Bausch Health Companies Inc.
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Gsk Plc
- 9.2.3. Abbott
- 9.2.4. Pfizer Inc.
- 9.2.5. Bayer Ag
- 9.2.6. Teva Pharmaceutical Industries, Ltd.
- 9.2.7. Cipla Inc.
- 9.2.8. Novartis Ag
- 9.2.9. Sun Pharmaceutical Industries Ltd.
- 9.2.10. Merck & Co., Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Onychomycosis Market, report scope
TABLE 2. Global Onychomycosis Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Onychomycosis Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Onychomycosis Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
TABLE 5. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Onychomycosis Market
TABLE 70. List of primary sources, used in the study of global Onychomycosis Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Onychomycosis Market, research methodology
FIG 2. Global Onychomycosis Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Onychomycosis Market, key trends 2021
FIG 5. Global Onychomycosis Market, growth prospects 2022-2029
FIG 6. Global Onychomycosis Market, porters 5 force model
FIG 7. Global Onychomycosis Market, pest analysis
FIG 8. Global Onychomycosis Market, value chain analysis
FIG 9. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Onychomycosis Market, regional snapshot 2019 & 2029
FIG 15. North America Onychomycosis Market 2019 & 2029 (USD Billion)
FIG 16. Europe Onychomycosis Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Onychomycosis Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Onychomycosis Market 2019 & 2029 (USD Billion)
FIG 19. Global Onychomycosis Market, company Market share analysis (2021)